62.48BMarket Cap31.09P/E (TTM)
23.48High22.95Low108.14KlotVolume23.10Open23.14Pre Close252.05MTurnover0.51%Turnover Ratio26.18P/E (Static)2.67BShares31.6652wk High1.35P/B49.53BFloat Cap20.3852wk Low25.45Limit Up2.12BShs Float90.71Historical High20.83Limit Down2.29%Amplitude-2.53Historical Low0.42Dividend TTM23.31Avg Price34.06KlotAsk1.80%Div YieldTTM100Lot Size72.50KlotBid
Shanghai Fosun Pharmaceutical Stock Forum
$FOSUN PHARMA(02196.HK)$ proposed to privatise $HENLIUS(02696.HK)$ at $24.6 per share. HENLIUS opened rocketing 21.3% at $22.85, while FOSUN PHARMA opened lifting 1.2% at...
Techs slid as the market continued to be watchful of the Sino-US relations:
$BABA-SW(09988.HK)$ dived 3.2% to $84.1.
$TENCENT(00700.HK)$ sank 1.9% to $338.4.
$MEITUAN-W(03690.HK)$ , $XIAOMI-W(01810.HK)$ , ...
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...
$Pfizer(PFE.US)$ $AIM VACCINE(06660.HK)$
Second, under the demand of stable growth, the industry policy margin is loose, such as the real estate industry chain and the Internet and other industries;
Third, under the theme of security for a long time, energy security, self contro...
$Sinovac Biotech(SVA.US)$ $FOSUN PHARMA(02196.HK)$ $Shanghai Fosun Pharmaceutical(600196.SH)$ $CanSino Biologics Inc.(688185.SH)$ $CANSINOBIO(06185.HK)$ $Walvax Biotechnology(300142.SZ)$ $Chongqing Zhifei Biological Products(300122.SZ)$
$FOSUN PHARMA(02196.HK)$ Fosun Pharma (02196.HK) yesterday disclosed the third quarterly report data, Q3 company revenue was 10.095 billion yuan, a year-on-year increase of 25.03%; net profit was 1.082 billion yuan, a year-on-year increase of 41.62%.
The growth of Fosun Pharma’s performance is due to alleviation of the pressure of centralized procurement and price reduction of stock varieties. According to the announcement, as of October 24, Fosun Pharma’s Fubitai (mRNA Covid-19 vaccine) has been vaccinated in Hong Kong, Macau and Taiwan over 9.7 million. Agent.
Article excerpted from the U.S. Stock Intelligence Agency
We added fosun Pharmaceutical today.
Because I want to be a butterfly
No comment yet